These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26562320)

  • 1. Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine.
    Giuntini S; Beernink PT; Granoff DM
    Vaccine; 2015 Dec; 33(51):7168-7175. PubMed ID: 26562320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
    Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.
    Granoff DM; Costa I; Konar M; Giuntini S; Van Rompay KK; Beernink PT
    J Infect Dis; 2015 Sep; 212(5):784-92. PubMed ID: 25676468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding.
    Costa I; Pajon R; Granoff DM
    mBio; 2014 Aug; 5(5):e01625-14. PubMed ID: 25161192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein.
    Sharkey K; Beernink PT; Langley JM; Gantt S; Quach C; Dold C; Liu Q; Galvan M; Granoff DM
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine.
    Pajon R; Lujan E; Granoff DM
    Vaccine; 2016 Jan; 34(5):643-649. PubMed ID: 26709637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?
    Granoff DM; Ram S; Beernink PT
    Clin Vaccine Immunol; 2013 Aug; 20(8):1099-107. PubMed ID: 23740919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein.
    Beernink PT; Giuntini S; Costa I; Lucas AH; Granoff DM
    mBio; 2015 Jun; 6(3):e00842. PubMed ID: 26106082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.
    Rossi R; Beernink PT; Giuntini S; Granoff DM
    Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
    Veggi D; Bianchi F; Santini L; Lo Surdo P; Chesterman CC; Pansegrau W; Bechi N; Huang Y; Masignani V; Pizza M; Rappuoli R; Bottomley MJ; Cozzi R; Maione D
    PLoS Pathog; 2020 Oct; 16(10):e1008882. PubMed ID: 33007046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines.
    Konar M; Granoff DM; Beernink PT
    J Infect Dis; 2013 Aug; 208(4):627-36. PubMed ID: 23715659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.
    Beernink PT; Shaughnessy J; Braga EM; Liu Q; Rice PA; Ram S; Granoff DM
    J Immunol; 2011 Mar; 186(6):3606-14. PubMed ID: 21325619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.
    Giuntini S; Pajon R; Ram S; Granoff DM
    Infect Immun; 2015 Apr; 83(4):1536-45. PubMed ID: 25644002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.
    Rossi R; Granoff DM; Beernink PT
    Vaccine; 2013 Nov; 31(46):5451-7. PubMed ID: 24035433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two human antibodies to a meningococcal serogroup B vaccine antigen enhance binding of complement Factor H by stabilizing the Factor H binding site.
    Sands NA; Beernink PT
    PLoS Pathog; 2021 Jun; 17(6):e1009655. PubMed ID: 34125873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in rhesus macaque complement factor H binding to meningococcal factor H binding protein (FHbp) informs selection of primates to assess immunogenicity of FHbp-based vaccines.
    Beernink PT; Shaughnessy J; Stefek H; Ram S; Granoff DM
    Clin Vaccine Immunol; 2014 Nov; 21(11):1505-11. PubMed ID: 25185576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.
    Rossi R; Konar M; Beernink PT
    Infect Immun; 2016 Jun; 84(6):1735-1742. PubMed ID: 27021245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.
    Beernink PT; Shaughnessy J; Pajon R; Braga EM; Ram S; Granoff DM
    PLoS Pathog; 2012; 8(5):e1002688. PubMed ID: 22589720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine.
    Lujan E; Partridge E; Giuntini S; Ram S; Granoff DM
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.
    Granoff DM; Giuntini S; Gowans FA; Lujan E; Sharkey K; Beernink PT
    JCI Insight; 2016 Sep; 1(14):e88907. PubMed ID: 27668287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.